At a glance
ClinicalIndex Comparison RecordN/ACompleted· 125 enrolled
Drug / intervention
AcrySof IQ Toric A-code IOL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
AcrySof IQ Toric A-Code Post-Market Clinical Study
In Brief
A clinical study evaluating AcrySof IQ Toric A-code IOL and Cataract surgery for Cataract and Astigmatism. Completed, enrolled 125 participants across 4 sites.
Detailed Summary
The purpose of this study is to clinically confirm the rotational stability of a modified AcrySof IQ toric intraocular lens (IOL) in a Japanese population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract, Astigmatism
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 2017
Enrollment StartJan 2018
Primary CompletionMay 2019
Study CompletionDec 2021
TodayJul 2026
First PostedNov 22, 2017
Enrollment StartJan 30, 2018
Primary CompletionMay 23, 2019
Study CompletionDec 17, 2021
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.6 years ago
Interventions
AcrySof IQ Toric A-code IOLdevice
Intended to provide visual acuity, including astigmatism correction, over the lifetime of the cataract patient
Cataract surgeryprocedure
Removal of cataractous lens and implantation of IOL